Eurofarma Innovation and Growth Strategy

GRUPO NC Hypera eurofarma SANOFI NOVARTIS 6,5% 22 22 OUTSTANDING POSITION Solid and Consistent Growth 1Q22 Pharmaceutical Market Share Brazil¹ #3 6,0% 5,9% 4,8% 4,2% 4,2% 3,7% 3,4% achē gsk Johnson Johnson novo nordisk Takeda (૫008 2,5% 2,2% 2,2% 2,1% 2,1% 2,0% 1,9% MSD União Química AstraZeneca CAGR Net Revenue 2019-20213 21% 18% Brazil Total 45% International Source: IQVIA: Retail Reais PPP/NRA Reais PP (Total Pharmaceutical Market, excluding Covid-19 vaccines) Mar/22 | 1- Eurofarma, Momenta and Supera; 2- Excluding multinational pharma companies not based in Latin America and Bolivia - MAT Feb/22; 3- Net revenue: R$4,828 mm (2019), R$5,723 mm (2020) and R$7,068 mm (2021). CIMED ROEMMERS eurofarma Hypera 4.0% #2 3.4% 3.2% LatAm² eurofarma

View entire presentation